CorrespondenceCan we increase male involvement in AIDS treatment?
References (5)
- et al.
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
Lancet
(2010) - et al.
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
J Womens Health
(2008)
Cited by (13)
Dividuality, masculine respectability and reputation: How masculinity affects men's uptake of HIV treatment in rural eastern Uganda
2013, Social Science and MedicineCitation Excerpt :Gender equality in access to HIV treatment in high prevalence settings, particularly sub-Saharan Africa (SSA), has attracted significant interest in recent years. Although women in most parts of SSA, and Uganda in particular, still have a higher prevalence of HIV than men (Ministry of Health (MoH) Uganda, ICF International, Calverton Maryland USA, Centers for Disease Control and Prevention Entebbe Uganda, Uganda, U. S. A. f. I. D. K., & WHO Kampala Uganda, 2012; UNAIDS, 2010), there is growing evidence that, once infected, men are more disadvantaged in terms of access to HIV treatment compared to women (Amuron et al., 2007; Birungi & Mills, 2010; Braitstein, Boulle, & Nash, 2008; Muula et al., 2007; Nattrass, 2008). In Uganda, compared to women fewer men are on HIV treatment, they tend to initiate treatment later, are difficult to retain on treatment and have higher mortality on treatment (Alibhai et al., 2010; Kigozi et al., 2009; Lubega et al., 2010; Mermin et al., 2008; Nakigozi et al., 2011).
Limited Impact of First-Line Drug Resistance Mutations on Virologic Response among Patients Receiving Second-Line Antiretroviral Therapy in Rural Uganda
2023, Journal of Acquired Immune Deficiency SyndromesClaudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
2020, Translational Cancer ResearchMen’s Refashioning of Masculine Identities in Uganda and Their Self-Management of HIV Treatment
2019, Qualitative Health Research